Daré Bioscience Announces Executive Team and Board of Directors Changes
SAN DIEGO, Jan. 26, 2024 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced changes in company management which includes the retirement of Chief Financial Officer, Lisa Walters-Hoffert, and the resignation of Chief Commercial Officer, John Fair. Both Ms. Walters-Hoffert and Mr. Fair have entered into plans with the Company to help ensure a seamless transition. Daré also announced an adjustment to the size of its Board of Directors to better reflect the Company’s size following the voluntary resignations of Cheryl R. Blanchard, Ph.D. and Sophia Ononye-Onyia, Ph.D.
Related news for (DARE)
- Stocks to Watch: Speculative Movers, Strategic Shifts, and a Big Bet on Live Entertainment
- Positive Ovaprene Interim Phase 3 Results Support Potential First-in-Class, Hormone-Free Monthly Contraceptive
- Today’s Top Performers: MoBot’s Market Review 07/11/25 08:00 AM
- Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders
- 24/7 Market News Snapshot 11 July, 2025 – Dare Bioscience, Inc. Common Stock (NASDAQ:DARE)